PharmaCyte Biotech
PMCB
PMCB
30 hedge funds and large institutions have $9.93M invested in PharmaCyte Biotech in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 7 closing their positions.
Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
6
Increased
9
Reduced
6
Closed
7
Calls
$522K
Puts
$566K
Net Calls
-$44K
Net Calls Change
+$1.42M
Top Buyers
1 |
KPF
1
K2 Principal Fund
Toronto,
Ontario, Canada
|
$2.15M |
2 |
FIA
2
FNY Investment Advisers
New York
|
$90K |
3 |
3
Jane Street
New York
|
$60.7K |
4 |
4
Citadel Advisors
Miami,
Florida
|
$51.1K |
5 |
5
Charles Schwab
San Francisco,
California
|
$50.3K |